Development of therapeutics for treatment of Ebola virus infection
- PMID: 25498866
- DOI: 10.1016/j.micinf.2014.11.012
Development of therapeutics for treatment of Ebola virus infection
Abstract
Ebola virus infection can cause Ebola virus disease (EVD). Patients usually show severe symptoms, and the fatality rate can reach up to 90%. No licensed medicine is available. In this review, development of therapeutics for treatment of Ebola virus infection and EVD will be discussed.
Keywords: Antibody; Ebola virus; Ebola virus disease; Small-molecule compounds; Therapeutics; Treatment.
Copyright © 2014 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
Similar articles
-
Small molecule inhibitors of ebola virus infection.Drug Discov Today. 2015 Feb;20(2):277-86. doi: 10.1016/j.drudis.2014.12.010. Epub 2014 Dec 19. Drug Discov Today. 2015. PMID: 25532798 Review.
-
Basic science and the Ebola virus infection epidemic.Pharmacotherapy. 2014 Nov;34(11):1115-7. doi: 10.1002/phar.1520. Pharmacotherapy. 2014. PMID: 25382095 No abstract available.
-
[Recent Advances in Vaccines and Drugs Against the Ebola Virus].Bing Du Xue Bao. 2015 May;31(3):287-92. Bing Du Xue Bao. 2015. PMID: 26470536 Review. Chinese.
-
Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus.Front Immunol. 2018 Aug 10;9:1803. doi: 10.3389/fimmu.2018.01803. eCollection 2018. Front Immunol. 2018. PMID: 30147687 Free PMC article. Review.
-
Development of Potential Small Molecule Therapeutics for Treatment of Ebola Virus Disease.Curr Med Chem. 2018;25(38):5177-5190. doi: 10.2174/0929867324666171010141416. Curr Med Chem. 2018. PMID: 29032747 Review.
Cited by
-
Antiviral Effects of Secondary Metabolites from Jatropha podagrica Leaves against the Pseudotyped Virus of SARS-CoV-2 Omicron.Plants (Basel). 2023 Nov 23;12(23):3942. doi: 10.3390/plants12233942. Plants (Basel). 2023. PMID: 38068579 Free PMC article.
-
Antisense oligonucleotides targeting ORF1b block replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).Front Microbiol. 2022 Oct 26;13:915202. doi: 10.3389/fmicb.2022.915202. eCollection 2022. Front Microbiol. 2022. PMID: 36386681 Free PMC article.
-
A Stochastic SEIRS Epidemic Model with Infection Forces and Intervention Strategies.J Healthc Eng. 2022 Jan 10;2022:4538045. doi: 10.1155/2022/4538045. eCollection 2022. J Healthc Eng. 2022. PMID: 35047150 Free PMC article. Retracted.
-
SHP-1 suppresses the antiviral innate immune response by targeting TRAF3.FASEB J. 2020 Sep;34(9):12392-12405. doi: 10.1096/fj.202000600RR. Epub 2020 Jul 23. FASEB J. 2020. PMID: 32779804 Free PMC article.
-
Artificial infectious disease optimization: A SEIQR epidemic dynamic model-based function optimization algorithm.Swarm Evol Comput. 2016 Apr;27:31-67. doi: 10.1016/j.swevo.2015.09.007. Epub 2015 Oct 9. Swarm Evol Comput. 2016. PMID: 32288989 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
